Literature DB >> 34709690

Heterogeneity of primary and secondary peristalsis in systemic sclerosis: A new model of "scleroderma esophagus".

Dustin A Carlson1, Jacqueline E Prescott1, Emma Germond1, Darren Brenner1, Mary Carns2, Chase S Correia2, Marie-Pier Tetreault1, Zsuzsanna H McMahan3, Monique Hinchcliff4, Wenjun Kou1, Peter J Kahrilas1, Harris R Perlman2, John E Pandolfino1.   

Abstract

BACKGROUND: Although esophageal dysmotility is common in systemic sclerosis (SSc)/scleroderma, little is known regarding the pathophysiology of motor abnormalities driving reflux severity and dysphagia. This study aimed to assess primary and secondary peristalsis in SSc using a comprehensive esophageal motility assessment applying high-resolution manometry (HRM) and functional luminal imaging probe (FLIP) Panometry.
METHODS: A total of 32 patients with scleroderma (28 female; ages 38-77; 20 limited SSc, 12 diffuse SSc) completed FLIP Panometry and HRM. Secondary peristalsis, i.e., contractile responses (CR), was classified on FLIP Panometry by pattern of contractility as normal (NCR), borderline (BCR), impaired/disordered (IDCR), or absent (ACR). Primary peristalsis on HRM was assessed according to the Chicago classification.
RESULTS: The manometric diagnoses were 56% (n = 18) absent contractility, 22% (n = 7) ineffective esophageal motility (IEM), and 22% (n = 7) normal motility. Secondary peristalsis (CRs) included 38% (n = 12) ACR, 38% (n = 12) IDCR, 19% (n = 6) BCR, and 15% (n = 5) NCR. The median (IQR) esophagogastric junction (EGJ) distensibility index (DI) was 5.8 mm2 /mmHg (4.8-10.1) mm2 /mmHg; EGJ-DI was >8.0 mm2 /mmHg in 31%, and >2.0 mm2 /mmHg in 100% of patients. Among 18 patients with absent contractility on HRM, 11 had ACR, 5 had IDCR, and 2 had BCR. Among 7 patients with IEM, 1 had ACR, 5 had IDCR, and 1 NCR. All of the patients with normal peristalsis had NCR or BCR.
CONCLUSIONS: This was the first study assessing combined HRM and FLIP Panometry in a cohort of SSc patients, which demonstrated heterogeneity in primary and secondary peristalsis. This complementary approach facilitates characterizing esophageal function in SSc, although future study to examine clinical outcomes remains necessary.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  aspiration; impedance; motility

Mesh:

Year:  2021        PMID: 34709690      PMCID: PMC9046463          DOI: 10.1111/nmo.14284

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.960


  24 in total

1.  The Functional Lumen Imaging Probe Detects Esophageal Contractility Not Observed With Manometry in Patients With Achalasia.

Authors:  Dustin A Carlson; Zhiyue Lin; Peter J Kahrilas; Joel Sternbach; Erica N Donnan; Laurel Friesen; Zoe Listernick; Benjamin Mogni; John E Pandolfino
Journal:  Gastroenterology       Date:  2015-08-14       Impact factor: 22.682

Review 2.  Esophageal disease in scleroderma.

Authors:  Ellen C Ebert
Journal:  J Clin Gastroenterol       Date:  2006-10       Impact factor: 3.062

3.  Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study.

Authors:  S Roman; A Hot; N Fabien; J-F Cordier; P Miossec; J Ninet; F Mion
Journal:  Dis Esophagus       Date:  2010-12-17       Impact factor: 3.429

4.  The relationship between esophageal acid exposure and the esophageal response to volumetric distention.

Authors:  D A Carlson; P Kathpalia; J Craft; M Tye; Z Lin; P J Kahrilas; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2017-11-02       Impact factor: 3.598

Review 5.  Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.

Authors:  Romy B Christmann; Athol U Wells; Vera L Capelozzi; Richard M Silver
Journal:  Semin Arthritis Rheum       Date:  2010-05-21       Impact factor: 5.532

6.  Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe.

Authors:  Dustin A Carlson; Peter J Kahrilas; Zhiyue Lin; Ikuo Hirano; Nirmala Gonsalves; Zoe Listernick; Katherine Ritter; Michael Tye; Fraukje A Ponds; Ian Wong; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-10-11       Impact factor: 10.864

7.  Predictors of survival in systemic sclerosis (scleroderma).

Authors:  R D Altman; T A Medsger; D A Bloch; B A Michel
Journal:  Arthritis Rheum       Date:  1991-04

8.  Effects of morphine and naloxone on esophageal motility and gastric emptying in man.

Authors:  R K Mittal; E B Frank; R C Lange; R W McCallum
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

9.  Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.

Authors:  J C Yarze; J Varga; D Stampfl; D O Castell; S A Jimenez
Journal:  Am J Gastroenterol       Date:  1993-06       Impact factor: 10.864

Review 10.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.